Jerzy Bełtowski
Department of Pathophysiology
Medical University
ul. Jaczewskiego 8
20-090 Lublin
Poland
Name/email consistency: high
- Phosphodiesterase 5 inhibitor ameliorates renal resistance to atrial natriuretic peptide associated with obesity and hyperleptinemia. Beltowski, J., Jamroz-Wisniewska, A., Borkowska, E., Marciniak, A. Arch. Med. Res. (2006)
- Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats. Beltowski, J., Jamroz-Wiśniewska, A., Borkowska, E., Wójcicka, G. Pharmacol. Res. (2005)
- Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia. Beltowski, J., Wójcicka, G., Jamroz-Wiśniewska, A., Borkowska, E., Marciniak, A. Life Sci. (2005)
- Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities. Bełtowski, J., Wójcicka, G., Jamroz, A. J. Cardiovasc. Pharmacol. (2004)
- Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. Bełtowski, J., Jochem, J., Wójcicka, G., Zwirska-Korczala, K. Regul. Pept. (2004)
- Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Bełtowski, J., Wójcicka, G., Jamroz, A. Atherosclerosis (2003)
- Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity. Bełtowski, J., Wójcicka, G., Jamroz, A. Obes. Res. (2003)









